Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys +/- Ribavirin for CHC Rollover Patients
NCT00800735Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 6
01
Overview
A Phase 3 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Roche. Started Apr 2009; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00800735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00800735.